TR201716207A2 - Pharmaceutical formulations containing vilanterol and umeclidinium. - Google Patents
Pharmaceutical formulations containing vilanterol and umeclidinium. Download PDFInfo
- Publication number
- TR201716207A2 TR201716207A2 TR2017/16207A TR201716207A TR201716207A2 TR 201716207 A2 TR201716207 A2 TR 201716207A2 TR 2017/16207 A TR2017/16207 A TR 2017/16207A TR 201716207 A TR201716207 A TR 201716207A TR 201716207 A2 TR201716207 A2 TR 201716207A2
- Authority
- TR
- Turkey
- Prior art keywords
- umeclidinium
- vilanterol
- pharmaceutical formulations
- formulations containing
- dry powder
- Prior art date
Links
- FVTWTVQXNAJTQP-UHFFFAOYSA-N diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol Chemical compound C=1C=CC=CC=1C(C12CC[N+](CCOCC=3C=CC=CC=3)(CC1)CC2)(O)C1=CC=CC=C1 FVTWTVQXNAJTQP-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229960004258 umeclidinium Drugs 0.000 title abstract 2
- DAFYYTQWSAWIGS-DEOSSOPVSA-N vilanterol Chemical compound C1=C(O)C(CO)=CC([C@@H](O)CNCCCCCCOCCOCC=2C(=CC=CC=2Cl)Cl)=C1 DAFYYTQWSAWIGS-DEOSSOPVSA-N 0.000 title abstract 2
- 229960004026 vilanterol Drugs 0.000 title abstract 2
- 239000000843 powder Substances 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Mevcut buluş, solunum yolu rahatsızlıklarında kullanılmak üzere, Vilanterol ve Umeklidinyumdan oluşan, kuru toz formundaki farmasötik formülasyonlara ilişkindir.The present invention relates to pharmaceutical formulations in dry powder form comprising Vilanterol and Umeclidinium for use in respiratory tract ailments.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/16238A TR201716238A1 (en) | 2017-10-18 | 2017-10-20 | New pharmaceutical compositions. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/16203A TR201716203A1 (en) | 2017-10-20 | 2017-10-20 | New umeclidinium formulations. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201716207A2 true TR201716207A2 (en) | 2019-05-21 |
Family
ID=67954794
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/16207A TR201716207A2 (en) | 2017-10-18 | 2017-10-20 | Pharmaceutical formulations containing vilanterol and umeclidinium. |
| TR2017/16203A TR201716203A1 (en) | 2017-09-30 | 2017-10-20 | New umeclidinium formulations. |
| TR2017/16209A TR201716209A2 (en) | 2017-09-30 | 2017-10-20 | New pharmaceutical compositions containing arformoterol and umeclidinium. |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/16203A TR201716203A1 (en) | 2017-09-30 | 2017-10-20 | New umeclidinium formulations. |
| TR2017/16209A TR201716209A2 (en) | 2017-09-30 | 2017-10-20 | New pharmaceutical compositions containing arformoterol and umeclidinium. |
Country Status (1)
| Country | Link |
|---|---|
| TR (3) | TR201716207A2 (en) |
-
2017
- 2017-10-20 TR TR2017/16207A patent/TR201716207A2/en unknown
- 2017-10-20 TR TR2017/16203A patent/TR201716203A1/en unknown
- 2017-10-20 TR TR2017/16209A patent/TR201716209A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR201716203A1 (en) | 2019-05-21 |
| TR201716209A2 (en) | 2019-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125595T1 (en) | DRY POWDER PREPARATION CONTAINING A CORTICOSTEROID AND A BETA-ADRENERGENT FOR INHALATION | |
| IL263709A (en) | Methods for the manufacture of cannabinoid prodrugs, pharmaceutical formulations and their use | |
| HUE061174T2 (en) | 1,3,4-oxadiazolesulfonamide derivative compounds as histone deacetylase-6 inhibitors and pharmaceutical preparations containing such compounds | |
| MX378273B (en) | ACTIVE COMPOUNDS TOWARDS BROMODOMAINS. | |
| DOP2017000306A (en) | PHARMACEUTICAL FORMULATIONS CONTAINING TENOFOVIR AND EMTRICITABINE | |
| MX388733B (en) | ANTIFUNGAL DRY POWDERS. | |
| IL283539A (en) | 3,3-difluoroallylamines or their salts and pharmaceutical preparations containing them | |
| DK3426294T3 (en) | Pharmaceutical formulation comprising antibody, cyclodextrin and methionine | |
| CY1122473T1 (en) | HIGH DOSE OPTIMIZED MID-SALIZED TABLET | |
| WO2016140933A3 (en) | Immediate release soluble ibuprofen compositions | |
| DK3429559T3 (en) | Palatable compositions containing sodium phenylbutyrate and uses thereof | |
| HUE057871T2 (en) | Hyaluronan conjugates, methods and compositions containing medicinal active ingredients | |
| AR108233A1 (en) | ORIC PHARMACEUTICAL COMPOSITIONS OF NICOTINAMIDE | |
| MX393915B (en) | NEW ORAL FORMULATIONS OF BELINOSTAT. | |
| MX390441B (en) | LIQUID PHOSPHAPLATIN FORMULATIONS. | |
| MX2018009948A (en) | Oritavancin formulations. | |
| TR201716207A2 (en) | Pharmaceutical formulations containing vilanterol and umeclidinium. | |
| EP3623384A4 (en) | ANTI-CLDN-5 ANTIBODIES, AND THE MEDICINAL PRODUCT CONTAINING IT | |
| EA201891848A1 (en) | PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF FIBROSIS | |
| LT3097921T (en) | COMPOSITIONS INCLUDING GERANIOL AND DRY GINGER FOR USE IN THE TREATMENT OF IRRITANT GUT SYNDROME | |
| TR201714725A1 (en) | DRY POWDER FORMULATION WITH BETA-2 AGONIST AND ANTICOLINERGIC | |
| TR201714728A1 (en) | Dry powder formulation containing Beta-2 Agonist and Corticosteroid. | |
| TR201714893A1 (en) | Dry powder composition containing Beta-2 Agonist and Corticosteroid. | |
| LV15003A (en) | A pharmaceutical composition for the control of weight gain | |
| EA202091403A1 (en) | 2-OXO-1-PYRROLIDINYLIMIDAZOTHIAZOLE DERIVATIVES |